Emerging therapeutic strategies in immune thrombocytopenia: an expert evaluation of the evolving treatment landscape

Therapeutic options for ITP are rapidly expanding beyond conventional immunosuppressants and splenectomy. Emerging targeted therapies offer the promise of improved efficacy, better safety profiles, and the potential for durable, treatment-free remission. Future research should focus on personalized medicine approaches, biomarker identification for predicting treatment response, optimizing treatment sequencing, and understanding long-term outcomes to transform ITP care.